Bharat Biotech
If there was SDG on COVID-19 management, India would have shown tremendous success
DCGI nod to Bharat Biotech's intranasal Covid vaccine for restricted emergency use
Bharat Biotech's Rotavac introduced in Nigeria to immunise children from diarrhoea
Bharat Biotech expects regulator's nod for intranasal COVID-19 vaccine in Aug
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech